The results suggested that ANKRD1 expression was an independent prognostic factor in COAD, GBM, HNSC, LUSC, and STAD, independent of known prognostic factors, such as TNM stage, gender, age, pharmaceutical treatment, and radiation treatment (P < 0.05) (Tables 1). Here, ANKRD1 is linked to glioblastoma.